News + Filings Transactions Holdings
All 13F 13D/G Other
|
NEW ENTERPRISE ASSOCIATES 13 LP
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
01/24/2023 |
SC 13D/A
| NEW ENTERPRISE ASSOCIATES 13 LP reports a 33.5% stake in Minerva Surgical, Inc. |
11/04/2022 |
SC 13D/A
| NEW ENTERPRISE ASSOCIATES 13 LP has filed a Schedule 13D for PhaseBio Pharmaceuticals, Inc. |
04/06/2020 |
SC 13D/A
| NEW ENTERPRISE ASSOCIATES 13 LP has filed a Schedule 13D for Ra Pharmaceuticals, Inc. |
01/14/2020 |
SC 13D/A
| NEW ENTERPRISE ASSOCIATES 13 LP reports a 6.4% stake in Dermira, Inc. |
10/17/2019 |
SC 13D/A
| NEW ENTERPRISE ASSOCIATES 13 LP reports a 13% stake in Ra Pharmaceuticals, Inc. |
07/08/2019 |
SC 13D/A
| NEW ENTERPRISE ASSOCIATES 13 LP has filed a Schedule 13D for Epizyme, Inc. |
01/30/2019 |
SC 13D/A
| NEW ENTERPRISE ASSOCIATES 13 LP has filed a Schedule 13D for TESARO, Inc. |
12/06/2018 |
SC 13D/A
| NEW ENTERPRISE ASSOCIATES 13 LP reports a 19% stake in TESARO, Inc. |
03/09/2018 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
02/27/2018 |
SC 13D/A
| NEW ENTERPRISE ASSOCIATES 13 LP reports a 17.7% stake in Ra Pharmaceuticals, Inc. |
09/28/2016 |
SC 13D/A
| Roka BioScience, Inc. reports a 37.9% stake in Roka Bioscience, Inc. |
03/28/2016 |
SC 13D/A
| TESARO, Inc. reports a 25.6% stake in TESARO, Inc. |
|
|